ABBV (AbbVie) EV-to-FCF (2024)

What is AbbVie EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, AbbVie's Enterprise Value is $329,271 Mil. AbbVie's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $21,891 Mil. Therefore, AbbVie's EV-to-FCF for today is 15.04.

The historical rank and industry rank for AbbVie's EV-to-FCF or its related term are showing as below:

ABBV' s EV-to-FCF Range Over the Past 10 Years
Min: 9.95 Med: 15.8 Max: 38.43
Current: 15.04

During the past 13 years, the highest EV-to-FCF of AbbVie was 38.43. The lowest was 9.95. And the median was 15.80.

ABBV's EV-to-FCF is ranked better than
65.85% of 530 companies
in the Drug Manufacturers industry
Industry Median: 22.78 vs ABBV: 15.04

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-30), AbbVie's stock price is $156.31. AbbVie's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $3.370. Therefore, AbbVie's PE Ratio for today is 46.38.

AbbVie EV-to-FCF Historical Data

The historical data trend for AbbVie's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie EV-to-FCF Chart

AbbVie Annual Data
TrendDec14Dec15Dec16Dec17Dec18Dec19Dec20Dec21Dec22Dec23
EV-to-FCF
Get a 7-Day Free Trial12.35 15.89 13.93 14.02 14.52
AbbVie Quarterly Data
Jun19Sep19Dec19Mar20Jun20Sep20Dec20Mar21Jun21Sep21Dec21Mar22Jun22Sep22Dec22Mar23Jun23Sep23Dec23Mar24
EV-to-FCFGet a 7-Day Free Trial14.31 11.70 12.56 14.52 17.24

Competitive Comparison of AbbVie's EV-to-FCF

For the Drug Manufacturers - General subindustry, AbbVie's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AbbVie's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where AbbVie's EV-to-FCF falls into.


AbbVie EV-to-FCF Calculation

AbbVie's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=329270.674/21891
=15.04

AbbVie's current Enterprise Value is $329,271 Mil.
AbbVie's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $21,891 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AbbVie(NYSE:ABBV) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

AbbVie's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=156.31/3.370
=46.38

AbbVie's share price for today is $156.31.
AbbVie's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.370.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

AbbVie EV-to-FCF Related Terms

Thank you for viewing the detailed overview of AbbVie's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

AbbVie (AbbVie) Business Description

Industry

GURUFOCUS.COM »STOCK LIST »Healthcare » Drug Manufacturers » AbbVie Inc (NYSE:ABBV) » Definitions » EV-to-FCF

Comparable Companies

MRK PFE JNJ AMGN BMY GILD BIIB OGN SCLX AMRN LLY XSWX:ROG LSE:AZN XSWX:NOVN XPAR:SAN LSE:GSK TSE:4568 TSE:4519 XTER:BAYN SHSE:600276

Traded in Other Exchanges

ABBV:Mexico 1ABBV:Italy 4ABd:UK 0QCV:UK 4AB0:Germany 4AB:Germany 4AB:Germany 4AB:Germany ABBV:Canada ABBV34:Brazil ABBV:Austria

Address

1 North Waukegan Road, North Chicago, IL, USA, 60064-6400

AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Executives

Nicholas Donoghoeofficer: SVP, Enterprise Innovation1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Susan E Quaggindirector1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Jennifer L. Davisdirector1 PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
Richard A Gonzalezofficer: Chairman of the Board and CEO1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Elaine K. Sorgofficer: Sr. V.P., U.S. Commercial Ops.1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Perry C Siatisofficer: EVP, GC and Secretary1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Jeffrey Ryan Stewartofficer: SVP, US Commercial Operations1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Kevin K Buckbeeofficer: SVP, Controller1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Scott T Reentsofficer: SVP, Chief Financial Officer1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Azita Saleki-gerhardtofficer: SVP, Operations1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Carrie C Stromofficer: SVP & Pres Global Allerg Aesth1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Roxanne S Austindirector200 N SEPULVEDA BLVD, PO BOX 956 MS ES/001/A102, EL SEGUNDO CA 90245
Timothy J. Richmondofficer: EVP, Chief HR Officer1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Michael Severinoofficer: EVP, R&D and CSO1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Henry O Gosebruchofficer: Chief Strategy Officer1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064-6092

AbbVie (AbbVie) Headlines

From GuruFocus

Abbvie Inc at Sanford C Bernstein Strategic Decisions Conference Transcript

By GuruFocus Research 01-22-2024

By GuruFocus Research 01-22-2024

Abbvie Inc at Morgan Stanley Global Healthcare Conference Transcript

By GuruFocus Research 01-22-2024

Abbvie Inc at Piper Sandler Healthcare Conference (Virtual) Transcript

By GuruFocus Research 01-22-2024

Abbvie Inc at Cowen Health Care Conference (Virtual) Transcript

By GuruFocus Research 01-22-2024

Abbvie Inc at Evercore ISI HealthCONx Virtual Conference Transcript

By GuruFocus Research 01-22-2024

Abbvie Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript

By GuruFocus Research 01-22-2024

Abbvie Inc at Barclays Global Healthcare Conference Transcript

By GuruFocus Research 01-22-2024

Abbvie Inc at Goldman Sachs Healthcare Conference Transcript

By GuruFocus Research 01-22-2024

Abbvie Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-22-2024

ABBV (AbbVie)  EV-to-FCF (2024)
Top Articles
Latest Posts
Article information

Author: Madonna Wisozk

Last Updated:

Views: 6660

Rating: 4.8 / 5 (68 voted)

Reviews: 83% of readers found this page helpful

Author information

Name: Madonna Wisozk

Birthday: 2001-02-23

Address: 656 Gerhold Summit, Sidneyberg, FL 78179-2512

Phone: +6742282696652

Job: Customer Banking Liaison

Hobby: Flower arranging, Yo-yoing, Tai chi, Rowing, Macrame, Urban exploration, Knife making

Introduction: My name is Madonna Wisozk, I am a attractive, healthy, thoughtful, faithful, open, vivacious, zany person who loves writing and wants to share my knowledge and understanding with you.